Tumor-normal sequencing reveals novel TP53 germline and clinically actionable somatic mutations in Nigerian breast cancer patientsAbimbola F. Onyia, Nwamaka Lasebikan, Oluwakemi A. Rotimi et al.|Cancer Genetics|2025Cited by 2